HOME » INVESTORS: NEWS RELEASES
2006 NEWS RELEASES
December
13, 2006
(PDF) - MIGENIX Reports Second Fiscal Quarter 2007 Financial Results
December 7, 2006
(PDF) - MIGENIX Second Fiscal Quarter 2007 Financial Results Conference Call
& Web Cast Notification
December 6, 2006
(PDF) -
MIGENIX Completes $11.6 Million Bought Deal Financing
November 16, 2006
(PDF) -
MIGENIX Announces C$10 Million Bought Deal Financing
November 15, 2006
(PDF) -
MIGENIX Releases CEO Message #19
November 6, 2006
(PDF) -
Celgosivir
Combination Therapy Demonstrates Positive Clinical Benefit in Chronic
Hepatitis C Non-Responder Patients
November 1, 2006
(PDF) -
MIGENIX to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
in New York
September 27, 2006
(PDF) -
MIGENIX to Present at the 46th Annual International Conference on
Antimicrobial Agents and Chemotherapy
September 26, 2006
(PDF) -
MIGENIX to Present at the UBS 2006 Global Life Science Conference
September 14, 2006
(PDF) -
MIGENIX reports First Quarter Fiscal Year 2007 Financial Results
September 14, 2006
(PDF) -
MIGENIX First Fiscal Quarter 2007 Financial Results Conference Call & Web
Cast Notification
August 29, 2006 (PDF) -
MIGENIX to Present
Celgosivir Synergy Data at the 13th International Meeting of
Hepatitis C Virus & Related Viruses
July 13, 2006
(PDF) - MIGENIX Reports Fourth Quarter and Fiscal Year 2006 Financial
Results
July 6, 2006
(PDF) - MIGENIX Fourth Quarter and Fiscal Year 2006 Financial Results
Conference Call & Web Cast Notification
June 15, 2006
(PDF) - MIGENIX Completes Enrollment of Celgosivir (MX-3253) Phase IIb
HCV Combination Study
May 25, 2006
(PDF) - MIGENIX Releases CEO Message #18
May 16, 2006
(PDF) - MIGENIX Receives Approval for MX-3253
Phase II Combination Viral Kinetics Study in HCV Treatment-Naïve Patients
May 4, 2006
(PDF) - MIGENIX Raises $8.8M
May 2, 2006
(PDF) - MIGENIX to Present at Several Upcoming Investor and Scientific
Conferences
May 1, 2006
(PDF) - AnnKatrin Petersen, M.D. Joins MIGENIX as VP Clinical Development
April 6, 2006
(PDF) - MIGENIX to Present at BIO 2006
March 8, 2006
(PDF) - MIGENIX Reports Third Quarter Fiscal Year 2006 Results
March 2, 2006 (PDF) - MIGENIX Third Quarter Fiscal 2006 Financial Results
Conference Call & Web Cast Notification
February 13, 2006 (PDF) -
MIGENIX to Participate in “Breakthroughs in Hepatitis” Focus Session at the
BIO CEO & Investor Conference in New York City
January 23, 2006 (PDF) -
MIGENIX to Initiate MX-3253 HCV Viral Kinetics Study in Treatment Naïve
Patients; CEO Message #17 Released
January 9, 2006 (PDF) -
MIGENIX Board Changes
|
